Compare UDR & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UDR | BIO |
|---|---|---|
| Founded | 1972 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 10.3B |
| IPO Year | 1994 | 1994 |
| Metric | UDR | BIO |
|---|---|---|
| Price | $36.31 | $369.50 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 22 | 3 |
| Target Price | $39.74 | ★ $356.67 |
| AVG Volume (30 Days) | ★ 4.7M | 239.9K |
| Earning Date | 11-02-2026 | 11-04-2026 |
| Dividend Yield | ★ 4.76% | N/A |
| EPS Growth | ★ 334.62 | 142.61 |
| EPS | 1.45 | ★ 11.25 |
| Revenue | $1,712,317,000.00 | ★ $2,583,200,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.99 | $1.86 |
| P/E Ratio | ★ $25.16 | $34.45 |
| Revenue Growth | ★ 2.42 | 0.65 |
| 52 Week Low | $33.10 | $236.73 |
| 52 Week High | $42.00 | $396.23 |
| Indicator | UDR | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 55.76 | 48.37 |
| Support Level | $33.71 | $350.89 |
| Resistance Level | $38.29 | $391.44 |
| Average True Range (ATR) | 0.85 | 12.91 |
| MACD | 0.10 | 0.69 |
| Stochastic Oscillator | 59.18 | 46.12 |
UDR Inc is a real estate investment trust that owns, operates, acquires, renovates, develops, redevelops, disposes of, and manages multifamily apartment communities in targeted markets located in the United States. The company has two reportable segments; Same-Store Communities segment represents those communities acquired, developed, and stabilized; and Non-Mature Communities/Other segment represents those communities that do not meet the criteria to be included in Same-Store Communities, including, but not limited to, recently acquired, developed and redeveloped communities, and the non-apartment components of mixed-use properties. It generates key revenue from Same-Store Communities.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.